Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126210172 | 12621017 | 2 | F | 20160727 | 20160804 | 20160804 | EXP | IT-TEVA-639189ACC | TEVA | ARCARI A,CHIAPPELLA A,SPINA M,ZANLARI L,BERNUZZI P,VALENTI V. | 0.00 | E | M | Y | 0.00000 | 20160805 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126210172 | 12621017 | 1 | PS | BENDAMUSTINE HYDROCHLORIDE. | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 190 MG, DAILY (CYCLIC) | U | 22249 | 190 | MG | POWDER FOR INJECTION | ||||||
| 126210172 | 12621017 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | U | 0 | ||||||||||
| 126210172 | 12621017 | 3 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126210172 | 12621017 | 1 | Diffuse large B-cell lymphoma refractory |
| 126210172 | 12621017 | 2 | Diffuse large B-cell lymphoma refractory |
| 126210172 | 12621017 | 3 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126210172 | 12621017 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126210172 | 12621017 | Acute kidney injury | |
| 126210172 | 12621017 | Dehydration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |